Suboxone and Subutex are both FDA approved drugs that are used to treat patients suffering from an opioid dependency. Only certified Suboxone doctors were given the green light to prescribe Buprenorphine and its variations (Suboxone &Subtex) after it replaced Methadone as the primary medication for opioid addiction treatment.
FDA listed Buprenorphine as a schedule III substance, which means that the potential for its abuse is lower as compared to Methadone ― a schedule II drug. Not only does this characterization prove that Buprenorphine is a safer option for the treatment of opioid addition but also the more effective one. In 2013, around 16000 doctors were permitted to prescribe Suboxone to patients, and an upward trend has been observed since then.
Buprenorphine is essentially a partial opioid agonist which has the ability to bind to opioid receptors in the brain. Initially, it was used to treat chronic pain, but after recognizing its underutilized importance, the FDA gave it the green light for Opioid addiction treatment.
So what is a partial opioid agonist?
Well, it’s like a full opioid agonist; the difference is that it doesn’t make you high like Heroin, when taken under the supervision of a prescribing doctor, in the recommended dosage. It helps patients keep their opioid cravings in check and prevents withdrawal symptoms.